Study on benign prostatic hyperplasia.
Not Applicable
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2023/07/054627
- Lead Sponsor
- JUNAIDH P
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Those cases above 40 years of age with symptoms of Benign prostatic hyperplasia
2.Cases with positive Ultrasound scan finding.
Exclusion Criteria
1.History of prostatitis,prostate CA,bladder CA
2.BPH with complication
3.Cases with serum PSA level above 10
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.TRANSABDOMINAL PELVIC ULTRASONOGRAPHY <br/ ><br>2.INTERNATIONAL PROSTATE SYMPTOM SCORE QUESTIONNAIRE. (IPSS)Timepoint: 1. 2 WEEKS <br/ ><br>2. 4 WEEKS
- Secondary Outcome Measures
Name Time Method 1.TRANSABDOMINAL PELVIC ULTRASONOGRAPHY <br/ ><br>2.INTERNATIONAL PROSTATE SYMPTOM SCORE QUESTIONNAIRE. (IPSS)Timepoint: 1. 3 WEEKS
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie homeopathic treatment efficacy in benign prostatic hyperplasia with lower urinary tract symptoms (LUTS)?
How does homeopathic therapy for BPH compare to standard-of-care treatments like alpha-blockers or 5-alpha reductase inhibitors in clinical trials?
What biomarkers correlate with ultrasound-measured prostate volume reduction in CTRI/2023/07/054627 homeopathic BPH trials?
Are there documented adverse events in homeopathic BPH trials using ultrasound assessment, and how do they compare to conventional therapies?
What combination approaches or alternative compounds synergize with homeopathic medicines for managing N401 BPH with LUTS?